Literature DB >> 7024401

Decrease of glutamate decarboxylase (GAD)-immunoreactive nerve terminals in the substantia nigra after kainic acid lesion of the striatum.

W H Oertel, D E Schmechel, M J Brownstein, M L Tappaz, D H Ransom, I J Kopin.   

Abstract

Antiserum sheep 3 against rat brain glutamate decarboxylase (GAD) was employed for the immunohistochemical localization of GAD-immunoreactive nerve terminals in the substantia nigra (SN). To test whether the antiserum specifically localized GAD-containing axon terminals, the effect of kainic acid-induced striatal lesions on the reactive nerve endings in the SN was investigated. Seven days after the injection of 1 microgram kainic acid into the striatum, a 65% decrease in GAD-enzyme activity occurred in the ipsilateral SN. On immunohistochemical examination there was correspondingly a marked reduction of GAD-positive terminals. The parallel decrease in biochemical and immunohistochemical GAD activity indicates that antiserum sheep 3 can be used as a specific immunohistochemical probed for GAD-containing elements.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7024401     DOI: 10.1177/29.8.7024401

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  8 in total

1.  Activity of neurochemically heterogeneous dopaminergic neurons in the substantia nigra during spontaneous and driven changes in brain state.

Authors:  Matthew T C Brown; Pablo Henny; J Paul Bolam; Peter J Magill
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

2.  Response properties of corticotectal and corticostriatal neurons in the posterior lateral suprasylvian cortex of the cat.

Authors:  T Niida; B E Stein; J G McHaffie
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

3.  Release of endogenous GABA from the substantia nigra is not controlled by GABA autoreceptors.

Authors:  P C Waldmeier; P Wicki; J J Feldtrauer; P A Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

4.  Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

Authors:  I Christensson-Nylander; M Herrera-Marschitz; W Staines; T Hökfelt; L Terenius; U Ungerstedt; C Cuello; W H Oertel; M Goldstein
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

5.  Characterization of extracellular GABA in the substantia nigra reticulata by means of brain microdialysis.

Authors:  W Timmerman; J Zwaveling; B H Westerink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-06       Impact factor: 3.000

6.  The lateral hypothalamic parvalbumin-immunoreactive (PV1) nucleus in rodents.

Authors:  Zoltán Mészár; Franck Girard; Clifford B Saper; Marco R Celio
Journal:  J Comp Neurol       Date:  2012-03-01       Impact factor: 3.215

7.  The GABAergic cerebello-olivary projection in the rat.

Authors:  B J Fredette; E Mugnaini
Journal:  Anat Embryol (Berl)       Date:  1991

8.  NMDA receptors in GABAergic synapses during postnatal development.

Authors:  Csaba Cserép; Eszter Szabadits; András Szőnyi; Masahiko Watanabe; Tamás F Freund; Gábor Nyiri
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.